Sector
PharmaceuticalsOpen
₹1,305Prev. Close
₹1,312.65Turnover(Lac.)
₹388.41Day's High
₹1,324.95Day's Low
₹1,286.152 Week's High
₹1,46952 Week's Low
₹1,004.45Book Value
₹288.82Face Value
₹10Mkt Cap (₹ Cr.)
5,399.74P/E
83.99EPS
15.59Divi. Yield
0.215 Sep 2023
12:00 AM
BookCloser
25 Aug 2023
12:00 AM
AGM
Announcement Date: 25 Aug, 2023
13 May 2023
12:00 AM
Dividend
Dividend Amount: 3
Record Date: 18 Sep, 2023
31 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 36.44 | 36.44 | 31.5 | 10.5 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 550.35 | 481.57 | 132.45 | 97.48 |
Net Worth | 586.79 | 518.01 | 163.95 | 107.98 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
|---|---|---|
Revenue | 520.13 | 340.6 |
yoy growth (%) | 52.7 | |
Raw materials | -272.83 | -179.68 |
As % of sales | 52.45 | 52.75 |
Employee costs | -41.36 | -20.98 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 |
|---|---|---|
Profit before tax | 91.45 | 71.72 |
Depreciation | -10.08 | -4.18 |
Tax paid | -19.5 | -17.72 |
Working capital | 186.55 | |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | 52.7 | |
Op profit growth | 31.13 | |
EBIT growth | 26.52 | |
Net profit growth | 33.23 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 717.47 | 616.73 | 520.14 | 340.61 | 239.64 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 717.47 | 616.73 | 520.14 | 340.61 | 239.64 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 7.49 | 4.32 | 2.76 | 1.38 | 2.84 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director
Nareshbhai Ramjibhai Patel
Whole-time Director
Chetankumar Chhaganlal Vaghasia
Whole-time Director
Virendra Nath Mishra
Whole-time Director
Ram Mohan Rao Locande
Independent Non Exe. Director
Girikrishna Maniar
Independent Non Exe. Director
Hetal Gandhi
Independent Non Exe. Director
Richa M. Goyal
Independent Non Exe. Director
Anita Bandyopadhyay
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Ami Organics Ltd
Summary
The Company was initially formed as a partnership firm in the name of Ami Organics with effect from 03 January 2004 at Surat, India. The firm converted into a private limited company under the Companies Act, 1956 under the name of Ami Organics Private Limited with a certificate of incorporation dated 12 June 2007. Subsequently, the Company was converted into a public limited company, following which the Companys name was changed to Ami Organics Limited, and a fresh certificate of incorporation was issued by RoC on 18 April 2018. The company is one of the leading research and development (R&D) driven manufacturers of specialty chemicals with varied end usage, focussed towards the development and manufacturing of advanced pharmaceutical intermediates for regulated and generic active pharmaceutical ingredients (APIs) and New Chemical Entities (NCE) and key starting material for agrochemical and fine chemicals, especially from the recent acquisition of the business of Gujarat Organics Limited (GOL). As per the F&S Report, the company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which the company manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, antiinflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globa
Read More
What is the Ami Organics Ltd share price today?
The Ami Organics Ltd shares price on N/A is Rs.₹1311 today.
What is the Market Cap of Ami Organics Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Ami Organics Ltd is ₹5362.72 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Ami Organics Ltd?
The PE and PB ratios of Ami Organics Ltd is 83.99 and 4.56 as of 22 Jul ‘24
What is the 52 Week High and Low of Ami Organics Ltd?
The 52-week high/low is the highest and lowest price at which a Ami Organics Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Ami Organics Ltd is ₹1005.05 and ₹1469.55 as of 22 Jul ‘24
What is the CAGR of Ami Organics Ltd?
Ami Organics Ltd's CAGR for 5 Years at N/I%, 3 Years at 11.90%, 1 Year at 12.19%, 6 Month at 15.55%, 3 Month at 9.75% and 1 Month at -4.38%.
What is the shareholding pattern of Ami Organics Ltd?
The shareholding pattern of Ami Organics Ltd is as follows:
Promoters - 35.98 %
Institutions - 27.73 %
Public - 36.29 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
